Ardelyx, Inc. (ARDX) stock
ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.09−0.03 (-0.96%)
Close on Nov 13, 2026Market cap $769.99MP/E –Yield –
Ardelyx profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Ardelyx's profit margin for the twelve months ending Jun 30, 2026 was -12.4%. For fiscal 2025 it was -15.1%, against -11.7% the year before. The highest annual figure on record is -10.2% in fiscal 2014.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -15.1% | −3.4 |
| FY2024 | Dec 31, 2024 | -11.7% | +41.4 |
| FY2023 | Dec 31, 2023 | -53.1% | +75.8 |
| FY2022 | Dec 31, 2022 | -128.9% | +1437.6 |
| FY2021 | Dec 31, 2021 | -1566.5% | −320.7 |
| FY2020 | Dec 31, 2020 | -1245.7% | +552.1 |
| FY2019 | Dec 31, 2019 | -1797.8% | +1704.3 |
| FY2018 | Dec 31, 2018 | -3502.0% | −3348.8 |
| FY2017 | Dec 31, 2017 | -153.2% | −29.9 |
| FY2015 | Dec 31, 2015 | -123.3% | −113.1 |
| FY2014 | Dec 31, 2014 | -10.2% | +12.5 |
| FY2013 | Dec 31, 2013 | -22.7% | +158.2 |
| FY2012 | Dec 31, 2012 | -180.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -13.8% | +5.7 |
| Q1 FY2026 | Mar 31, 2026 | -39.8% | +15.7 |
| Q4 FY2025 | Dec 31, 2025 | -0.3% | −4.3 |
| Q3 FY2025 | Sep 30, 2025 | -0.9% | −0.1 |
| Q2 FY2025 | Jun 30, 2025 | -19.5% | +2.9 |
| Q1 FY2025 | Mar 31, 2025 | -55.5% | +2.1 |
| Q4 FY2024 | Dec 31, 2024 | 4.0% | +87.8 |
| Q3 FY2024 | Sep 30, 2024 | -0.8% | −12.6 |
| Q2 FY2024 | Jun 30, 2024 | -22.5% | +54.2 |
| Q1 FY2024 | Mar 31, 2024 | -57.6% | +177.9 |
| Q4 FY2023 | Dec 31, 2023 | -83.8% | −108.0 |
| Q3 FY2023 | Sep 30, 2023 | 11.8% | +470.9 |
| Q2 FY2023 | Jun 30, 2023 | -76.7% | +989.8 |
| Q1 FY2023 | Mar 31, 2023 | -235.5% | +5762.6 |
| Q4 FY2022 | Dec 31, 2022 | 24.2% | +3545.5 |
| Q3 FY2022 | Sep 30, 2022 | -459.1% | +3256.7 |
| Q2 FY2022 | Jun 30, 2022 | -1066.4% | +2375.2 |
| Q1 FY2022 | Mar 31, 2022 | -5998.1% | −5494.4 |
| Q4 FY2021 | Dec 31, 2021 | -3521.3% | −1925.0 |
| Q3 FY2021 | Sep 30, 2021 | -3715.9% | −3048.4 |
| Q2 FY2021 | Jun 30, 2021 | -3441.7% | −2082.4 |
| Q1 FY2021 | Mar 31, 2021 | -503.7% | +1340.7 |
| Q4 FY2020 | Dec 31, 2020 | -1596.2% | −716.7 |
| Q3 FY2020 | Sep 30, 2020 | -667.5% | +113.8 |
| Q2 FY2020 | Jun 30, 2020 | -1359.3% | +140124.1 |
| Q1 FY2020 | Mar 31, 2020 | -1844.4% | +30934.4 |
| Q4 FY2019 | Dec 31, 2019 | -879.6% | +13147.2 |
| Q3 FY2019 | Sep 30, 2019 | -781.2% | +73522.1 |
| Q2 FY2019 | Jun 30, 2019 | -141483.3% | −140749.8 |
| Q4 FY2018 | Dec 31, 2018 | -32778.8% | −32802.9 |
| Q3 FY2018 | Sep 30, 2018 | -14026.7% | – |
| Q2 FY2018 | Jun 30, 2018 | -74303.3% | – |
| Q1 FY2018 | Mar 31, 2018 | -733.6% | – |
| Q4 FY2017 | Dec 31, 2017 | 24.1% | – |
See a number that looks wrong?